Tablet-Pro's unique design allows it to fully automate tablet content uniformity testing and stability analysis, leading to higher throughput rates than currently available.
"Current industry expectations are one tablet every 30 minutes, creating backlogs in batch testing. The Tablet-Pro can analyse one tablet every 18 minutes, so throughput times are effectively doubled and backlogs reduced," Anthony Moran, >Astech's Business Development Manager, told In-PharmaTechnologist.com.
"In addition, the system can accommodate parallel processing, to allow more than one tablet to be analysed at once. Throughput is restricted only by the number of modules used and improved scalability allows users to specify the number of homogenisers, vessel size and volumes for dissolution," he said.
Running costs are also reduced by a novel filtration system, which removes the need for expensive consumables.
The issue of backlog is a problem within the pharmaceutical manufacturing industry. It is required that ten tablets in every thousand manufactured undergo quality control processing.
Backlogs created by current tablet analysis systems can delay product release by days.
"The current market for tablet quality control processing systems is pretty stagnant, most equipment being used in pharmaceutical manufacturing is at least 15 years old and uses outdated technology," said Moran.
"No other drug content analysis system offers all the unique features of the Tablet-Pro," he said.
